Ubuntu Unity 24.04 arrives along with new little sibling, Ubuntu Lomiri
. Although it's only a modest change over previous releases, there are a few differences in this release – and what's more, it now has a sibling distro with the desktop formerly known as Unity 8.release is the"Noble Numbat" version of Ubuntu Unity. The distro itself isn't dramatically different from the previous releases – which is good thing in a LTS release. Version 24.04 uses the same Unity 7.7 desktop as in version 23.
We tried it both in VirtualBox 7.18 and on the bare metal of our venerable Thinkpad W500, and it worked – not perfectly, but much better than the Debian 12 version on either. We also tried it on a geriatric Thinkpad X61 tablet, the only x86 machine with a touchscreen in the Irish Sea wing of Vulture Towers. To our pleased surprise, it also worked fine even on this very low-end hardware – a Core 2 Duo with 2GB of RAM – but sadly without any touch support.
Ubuntu Lomiri also offers a quite broad selection of apps, although some typical Ubuntu ones don't work so aren't included. - Click to enlarge
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Xubuntu 24.04: A minimal install that does what it says on the tinThis nearly Snap-free Ubuntu remix may be about about to win friends and influence people
Read more »
Ubuntu 24.04, Fedora 40, EndeavourOS, and TrueNAS 24.04 all arrive at onceSometimes Linux releases are like buses… frequently clustered together, and rarely as reliable as you might ideally want
Read more »
Qt Ubuntu 24.04 betas show that there's room to innovateHot on the heels of Ubuntu Noble beta come the betas of the Qt-based remixes, with some interesting differences
Read more »
After delay due to xz, Ubuntu 24.04 'Noble Numbat' belatedly hits betaKernel 6.8, GNOME 46, and more apps in Snap packages
Read more »
Pfizer pauses trial for experimental gene therapy drug after child participant dies suddenlyThe boy, who was aged between two and four, suffered a cardiac arrest after receiving the one-off gene therapy last year. It was poised to become one of the world's most expensive drugs.
Read more »
Pfizer pauses trial for experimental gene therapy drug after child participant dies suddenlyThe boy, who was aged between two and four, suffered a cardiac arrest after receiving the one-off gene therapy last year. It was poised to become one of the world's most expensive drugs.
Read more »